Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)

Clinical trial NCT00724373 · COMPLETED

Trial details

NCT number: NCT00724373
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C, Chronic

Start date: 2007-11-01
Primary completion: 2009-02-01
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.